This study investigated the efficacy of a new ilioinguinal-transversus abdominis plane block when used as a component of multimodal analgesia. We conducted a prospective, triple-blind, placebo-controlled randomised study of 100 women undergoing elective caesarean section. All women had spinal anaesthesia with hyperbaric bupivacaine, 15 lg fentanyl and 150 lg morphine, as well as 100 mg diclofenac and 1.5 g paracetamol rectally. Women were randomly allocated to receive the ilioinguinal-transversus abdominis plane block or a sham block at the end of surgery. The primary outcome was the difference in fentanyl patient-controlled analgesia dose at 24 h. Secondary outcomes included postoperative pain scores, adverse effects and maternal satisfaction. The cumulative mean (95%CI) fentanyl dose at 24 h was 71.9 (55.6-92.7) lg in the ilioinguinal-transversus abdominis group compared with 179.1 (138.5-231.4) lg in the control group (p < 0.001). Visual analogue scale pain scores averaged across time-points were 1.9 (1.5-2.3) mm vs. 5.0 (4.3-5.9) mm (p = 0.006) at rest, and 4.7 (4.1-5.5) mm vs. 11.3 (9.9-13.0) mm (p = 0.001) on movement, respectively. Post-hoc analysis showed that the ilioinguinal-transversus abdominis group was less likely to use ≥ 1000 lg fentanyl compared with the control group (2% vs. 16%; p = 0.016). There were no differences in opioid-related side-effects or maternal satisfaction with analgesia. The addition of the ilioinguinal-transversus abdominis plane block provides superior analgesia to our usual multimodal analgesic regimen.
Introduction
Caesarean section is one of the most common major surgical procedures. Pain severity after caesarean section has been ranked ninth out of 179 surgical procedures [1] , with moderate or severe pain reported in 7% of women [2] . Postoperative analgesia may be applied less effectively than after hysterectomy, as patients experience higher pain scores, receive less opioids and describe a greater interference of pain with outcomes such as movement and walking [3] .
The ilioinguinal-iliohypogastric block [4, 5] and the transversus abdominis plane (TAP) block [6] [7] [8] [9] [10] [11] have been shown to reduce postoperative opioid requirements after lower abdominal surgery. The majority of studies compare these nerve blocks either with a control group who have oral or intravenous (i.v.) opioids, or with spinal morphine; however, they do not show a benefit in postoperative analgesia compared with spinal morphine [12] [13] [14] .
We have noted that a proportion of patients in the recovery area develop pain, despite having included morphine in the spinal. After appreciating the similarities in the anatomical planes that are used in the ilioinguinal-iliohypogastric and TAP blocks, anaesthetists at our department successfully used a combined ilioinguinal-transversus abdominis plane (I-TAP) nerve block for 18 months before this trial, with observed improvements in analgesia. Since the ilioinguinal-iliohypogastric and TAP blocks have already been widely used, extensively researched and reported in the literature, a pilot study was not conducted. We performed this prospective, randomised, placebo-controlled, trial to formally test the efficacy of the I-TAP block. We hypothesised that the addition of the I-TAP block to a multimodal analgesic regimen that included spinal morphine would reduce fentanyl consumption over the first 24 postoperative hours.
Methods
This randomised, sham-controlled, triple-blind study was approved by the Central Adelaide Local Health Network Human Research Ethics Committee, as well as the participating site. Patients were contacted through the antenatal clinic or by telephone to assess eligibility and discuss the trial. On the day of surgery we obtained written informed consent on admission to the ward.
We recruited women ≥ 18 years and ≥ 65 kg who were scheduled for elective caesarean section with spinal anaesthesia between February and July 2016.
We did not include women who were unable to consent; who had insufficient comprehension of English to understand the study protocol; had an allergy to morphine or local anaesthetic; progressive neurological disease, chronic opioid use or chronic pain syndromes; a diagnosis of schizophrenia or bipolar affective disorder; or those who were enrolled as part of our 'enhanced recovery at elective caesarean section' (EREC) protocol. Women who required conversion to a general anaesthetic would not be studied after random allocation.
Spinal anaesthesia was provided using 1.7-2.7 ml hyperbaric bupivacaine 0.5%, according to the preference of the treating anaesthetist, together with 15 lg fentanyl and 150 lg morphine. Rectal paracetamol 1.5 g and diclofenac 100 mg were administered at the end of surgery, unless contraindicated.
Once in the recovery area, the block was performed by one of five anaesthetists (DC, RC, TL, MP, JS) who had no further contact with the patient. The patient was monitored by continuous verbal contact, pulse oximetry and non-invasive blood pressure throughout the procedure and for the remainder of the recovery area admission. The curtains were drawn around the patient, a screen was placed across the patient's abdomen to block their view and no other staff were present. The spinal anaesthetic was checked to ensure that it was providing sufficient anaesthesia at the needle insertion points.
Patients were randomly allocated by sealed envelope to the I-TAP group or a control group having a sham block, according to a computer-generated sequence prepared by our statistician.
Aseptic technique was used for all patients. In the I-TAP group, an insertion point approximately 2 cm medial and 2 cm superior to the anterior superior iliac spine was identified. A short-bevelled needle (21-G 100 mm SonoPlex stim cannula; Pajunk, Medizintechnologie GmbH, Geisingen, Germany) was advanced perpendicularly to the skin until the first fascial pop was felt. After negative aspiration, 10 ml ropivacaine 0.33% was injected between the internal oblique and external oblique muscles. The needle was then advanced until a second fascial pop was felt. After negative aspiration, 20 ml ropivacaine 0.33% was injected in the transversus abdominis plane. The needle was withdrawn and the insertion site covered with a small dressing. The procedure was repeated on the contralateral side. A total of 200 mg of ropivacaine in 60 ml was used.
In the control group, using the same skin landmark, a sham block was performed using a blunt needle with no skin penetration to simulate the pressure sensation on the skin. Time for injection was simulated with a prolonged pause. The site was covered with a small dressing.
If the patient had pain in the recovery area, the protocol was to give a 10 lg i.v. fentanyl bolus for numeric rating scale (NRS) < 7 on a 0-10 scale, or a 20 lg bolus for NRS ≥ 7, up to a maximum of 400 lg before review by an anaesthetist. A patient-controlled analgesia (PCA) pump was set up using fentanyl with a 10 lg bolus dose, 5-min lockout and no background infusion. The bolus dose could be increased to 20 lg at the discretion of the treating midwife or acute pain service if 10 lg was thought to be inadequate. All patients were given oral paracetamol 1 g four times a day, and diclofenac 50 mg three times a day unless contraindicated.
The primary outcome was total fentanyl consumption at 24 h. Secondary outcomes included: pain at rest and on movement using a 0-100 mm visual analogue scale (VAS); sedation (score 0 -no sedation, 1 -easy to rouse, 2 -easy to rouse but difficulty staying awake, 3 -somnolent and difficult to rouse); nausea and vomiting requiring treatment; and pruritus requiring treatment over the first 24 h. Maternal satisfaction with analgesia (5-point Likert scale; 1 -strongly disagree; 2 -disagree; 3 -neutral; 4 -agree 5 -strongly agree) and requirement for additional analgesia (provided at the discretion of the acute pain service) was assessed at 24 h.
The sample size was based on a study of ilioinguinal-iliohypogastric nerve block by Bell et al. using a morphine PCA that included 90 participants, which showed a difference between groups in opioid use at 24 h of 19 (pooled SD 27.6) mg [15] ; this sample size would give power of 0.9 at α of 0.05, using a two-sample, two-tailed Student's t-test. We planned on recruiting 100 women to account for drop-outs. We included repeated measures of opioid consumption, and by using a mixed experimental design with fixed effects of treatment group and random effects of time this provided greater statistical power than Bell et al. [15] .
Statistical analysis was performed by our statistician, who was blinded to group allocation, with an intentionto-treat approach using Stata/IC 14.0 (StataCorp, College Station, TX, USA). We used ANOVA for continuous, between-subjects variables, and repeated measures ANOVA for comparisons at multiple time-points. However, residual analysis of cumulative fentanyl dose and VAS on rest and on movement showed violation of model assumptions, therefore, logarithmic transformations were applied, with corresponding improvement of residuals. Binary outcome data were analysed using logistic regression, or Fisher's exact test at each timepoint if not possible due to multicollinearity in the nested logistic regression model. Ordinal data were analysed using ordinal logistic regression using analgesia type as the predictor variable. Post-hoc analysis of patients requiring fentanyl ≥ 1000 lg was conducted using Fisher's exact test and backwards stepwise logistic regression. All analyses used a = 0.05 with no family-wise corrections.
Results Figure 1 shows the CONSORT diagram for the trial. Three patients were withdrawn before trial completion, including one patient from the I-TAP group who developed a femoral nerve block that resolved over the next day. All data were included in accordance with the intention-to-treat principles. Baseline characteristics and clinical features of the patients are presented in Table 1 .
There was a difference in total fentanyl consumption between the treatment groups (F 1,386 = 22.11; p < 0.001) and time-points (F 4,386 = 172.04; p < 0.001), but their interaction was not significant (F 4,386 = 1.58; p = 0.180; Table 2 , Fig. 2 ). Planned comparisons showed reductions in total fentanyl consumption in the I-TAP group at all time-points ( Table 2) . At 24 h, mean (95%CI) total fentanyl consumption was 71.9 (55.6-92.7) lg in the I-TAP group compared with 179.1 (138.5-231.4) lg in the control group. This was a reduction of 107.2 (41.6-71.6) lg (p < 0.001), that is, 59.3 (41.6-71.6)%.
There were statistically significant reductions in VAS pain scores at both rest (F 1,382 = 12.72; p = 0.001) and on movement (F 1,379 = 11.30; p = 0.001) in the I-TAP group compared with control ( Table 2 ). The differences in VAS scores between groups were greatest at 4 h (p < 0.001).
There were no significant differences in opioidrelated adverse effects between the groups. Maternal satisfaction with analgesia was similar between both groups (p = 0.418; Table 2 ). Additional analgesia was required by one patient in the I-TAP group and six in the control group (p = 0.059).
During data entry, it was noted there was a number of patients that used a high dose of PCA fentanyl. In a post-hoc analysis, we compared cumulative fentanyl dose ≥ 1000 lg at 24 h between groups. The control group was more likely to use a higher amount of fentanyl (16% vs. 2%; p = 0.016). Backwards stepwise logistic regression was performed using patient variables to identify predictive characteristics of patients requiring ≥ 1000 lg fentanyl. There was no statistically significant correlation between the use of fentanyl and patient characteristics, except for the allocated cohort (I-TAP or control).
Discussion
This trial demonstrated that the addition of the I-TAP block to a multi-modal analgesic regimen resulted in a 59% reduction in total PCA fentanyl dose over the first 24 h after elective caesarean section. Furthermore, there was a reduction in pain scores both at rest and on movement.
We expected there to be no difference in VAS between the groups as the women were able to adjust their own analgesia using PCA. Although the differences in VAS scores were statistically significant, the effect size was clinically small. At the 4-h time-point there was a difference of 12.5 mm in VAS on movement. A difference in VAS of greater than 9 mm has been accepted to be a clinically significant difference [16, 17] . We believe this difference may be consistent with the slower onset of spinal morphine compared with the I-TAP block.
Multiple studies have documented the benefit of the ilioinguinal-iliohypogastric and TAP blocks in lower abdominal surgery, but have not conclusively shown utility at caesarean section [4, 5, 7, 9, 10, 12, 13, 15, 18] . Spinal morphine has now become commonplace for postoperative analgesia at caesarean section. The majority of studies compare the ilioinguinal-iliohypogastric block or the TAP block with spinal morphine, or with parenteral opioids without the use of spinal morphine. The few studies that have compared a nerve block in addition to spinal morphine have failed to show a significant reduction in opioid dose or pain scores [12] [13] [14] . The current efficacy study is superior because it compares a new combined nerve block technique in addition to spinal morphine.
The I-TAP block combines the concept of a compartment block used in a TAP block as well as targeting specific nerves used in the ilioinguinaliliohypogastric block (Fig. 3) . The TAP block is a compartment block requiring a large volume of approximately 20 ml local anaesthetic placed in the plane between the internal oblique muscle and the transversus abdominis muscle. This plane can be accessed at multiple points, and is commonly approached posteriorly via the triangle of Petit or laterally with the use of an ultrasound. The literature describes the TAP block covering nerves T10-L1. However, Lee et al. demonstrated that an ultrasoundguided TAP block failed to provide an L1 sensory block in > 50% of patients, suggesting that the local anaesthetic from a posterior or subcostal TAP block does not reliably cover the ilioinguinal and iliohypogastric nerves [19] . A more anterior approach such as that used in the I-TAP block may cover the L1 dermatome more reliably, as the ilioinguinal and the iliohypogastric nerves often do not pass through the internal and external oblique muscles until they are near the anterior superior iliac spine [10, 20] .
The ilioinguinal-iliohypogastric block specifically targets these two nerves, but fails to cover the subcostal nerve contribution to the lower abdomen. The I-TAP block uses the same insertion point as the traditional ilioinguinal-iliohypogastric block, but uses a larger volume of dilute local anaesthetic to facilitate spread through the fascial plane.
The landmark approach to the TAP block at the triangle of Petit results in spread to the paravertebral spaces between T4 and L1, as demonstrated in MRI studies [21, 22] . This spread may act to reduce the visceral component of pain. Although the anterior TAP approach did not demonstrate significant paravertebral spread in these studies, our results demonstrated a reduction in pain scores at rest as well as movement. This suggests that there may be a visceral analgesic component to the block. It is possible that the systemic absorption of local anaesthetic from the compartment also contributed to the analgesic effect [23] . This study has demonstrated that the I-TAP block has an independent analgesic effect. There were also significantly fewer patients who required ≥ 1000 lg fentanyl in the I-TAP group. The I-TAP might be used as a postoperative rescue technique when the standard analgesic regimen is ineffective.
Femoral nerve block remained the only complication noted during the trial. There are sporadic case reports of femoral nerve block with the ilioinguinaliliohypogastric nerve block in the literature, which are thought to be due to the spread of the local anaesthetic down the transversalis fascia to the fascia iliaca and femoral nerve [24, 25] . Although this occurred only once, our study was underpowered to demonstrate the safety profile of the block. There remains the risk of peritoneal puncture with this technique, which is reduced with the use of a short-bevelled needle. A literature review of four trials using the landmark approach to a TAP block, including 196 patients, failed to demonstrate any complications attributable to the block [7, 8, 14, 26] . Reported cases of peritoneal puncture and organ injury are uncommon, most of which were managed conservatively [27] [28] [29] [30] [31] . There are no published series examining the safety of truncal regional anaesthesia using ultrasound compared with the landmark approach. Although McDermott et al. demonstrated that the landmark approach was associated with inaccurate needle placement, no complications were noted in any of those who had a peritoneal puncture [32] . There was also no comparison with ultrasound-guided TAP blocks, and rates of peritoneal puncture were vastly different between clinicians performing the block. The 2010 American Society of Regional Anesthesia assessment of ultrasound-guided regional anaesthesia states "no definitive statements can be made regarding improvements in success rates or reduction in the frequency of complications" [33] . In fact, a cadaveric study of ultrasound-guided TAP blocks demonstrated contrast in the peritoneal space on CT despite needle visualisation with ultrasound [34] . We chose not to use ultrasound in the current study, as a landmark procedure would have a broader application in resource-constrained clinical settings. The block can be easily performed under ultrasound if so desired.
There is a risk of local anaesthetic toxicity with regional nerve blocks, although this has not been shown to be a problem with TAP blocks. A total of 200 mg of ropivacaine in 60 ml was selected for all weights as it provided uniformity of volume and concentration across patients. Thus, we did not include those under the weight of 65 kg as they were not within the safe ropivacaine range. Griffiths et al. demonstrated the mean peak plasma concentration of ropivacaine after a 3 mg.kg À1 TAP block was 2.5 lg.ml À1 [35] . Similarly, Yasumara et al. demonstrated maximum levobupivacaine plasma levels of 2.3 lg.ml À1 in a TAP block using 2.5 mg.kg À1 levobupivacaine [36] . Although these levels exceed the i.v. toxic levels of 2.2 lg.ml À1 based on healthy volunteer studies, no adverse effects were demonstrated, and they are similar to levels seen with axillary block [24, 25] . A placebo of injecting saline was not used due to the controversial ethical considerations of exposing a patient to an invasive procedure with no gain [37, 38] .
There are several limitations to the current trial. The study period of 24 h does not necessarily adequately reflect the clinical time course of acute postoperative pain.
However, we would expect pain scores to be maximal in both groups by 24 h. Regional nerve blocks produce loss of sensation and makes blinding difficult to achieve. We did not assess each block for dermatomal distribution, or estimate success/failure, as this would affect blinding negatively.
The largest exclusion group in the current study was 54 women on the EREC protocol. They were not included as they would have a different mobilisation regimen that could bias analgesic use, and would be discharged before completion of the study protocol. However, we believe that this subset of women do not differ significantly from the general caesarean section population.
The current study investigated the efficacy, but not the effectiveness, of the I-TAP block. We plan, in future studies, to compare it with the ilioinguinal-iliohypogastric block, the TAP block and local anaesthetic infiltration. We have used this block with good effect in other open lower abdominal surgery such as inguinal hernia repair, Figure 2 Cumulative PCA fentanyl dose after caesarean section in women receiving the I-TAP block (circle) or control (X). Error bars are 95%CI.
total abdominal hysterectomy and hand-assisted laparoscopic bowel resection. It would be useful to investigate the efficacy and effectiveness of the I-TAP block for such surgical procedures.
In summary, when added to a multimodal analgesic regime of spinal morphine, paracetamol and non-steroidal anti-inflammatory drugs after caesarean section, the I-TAP block reduces PCA fentanyl dose and pain scores. 
